The cost-effectiveness watchdog ICER found that Vertex’s future non-opioid treatment for acute pain could be cost-saving, but only at a low price, according to a …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Share this article The deal will enhance Kyowa Kirin’s focus on addressing the unmet medical needs of individuals with genetic and other severe diseases. Credit:
A pioneering research study announced today (October 23) will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of
At its conference in Bilbao, the European Economic and Social Committee (EESC) urged the European Union to launch a European action plan stepping up cooperation between